Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Tablets Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2022 Category: Research Source Type: clinical trials
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2022 Category: Research Source Type: clinical trials
Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Tablets Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Tablets Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Tablets Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Tablets Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Tablets Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Intervention: Drug: Bisoprolol Fumarate Sponsors: Damanhour University; Alexandria University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2022 Category: Research Source Type: clinical trials